Skip to content
The Post-Finasteride Syndrome Foundation Logo
  • English
  •  Español
  •  Chinese
  •  Russian
  • Hindi
  • Menu
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
  • Home
  • What Is PFS
    • What Is PFS?
    • Diagnostic Criteria
    • FAQs
    • PFS by the Numbers
  • Resources
    • Medical Professionals
    • Support Program Connects PFS Patients Worldwide
    • Medical Literature
    • Report Your Side Effects
    • PFS Global Warning Map
    • Online Patient Support
    • PFS Brain Bank
  • News
    • Foundation Newsroom
    • Propecia Litigation Library
    • PFS Media Awareness
    • Doctors & Researchers Speaking Out
    • PFS Quilt
  • Clinical Trials
  • About Us
  • Contact Us
  • Donate Now
  • Menu

A greatly under-recognised and often devastating condition.

A greatly under-recognised and often devastating condition: “Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.”

—Referring, via Twitter, to Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin: Sept. 7, 2022

Post navigation

← [S]houldn’t we be quite worried…
Damn near over the counter. →

Join Our Mailing List

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
First Name*
Are you a...*
The Post-Finasteride Syndrome Foundation © 2026 Theme by SiteOrigin